Icatibant

Create: 01/15/2017

Expired Date:	never
Category:	Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:	Icatibant (Firazyr) is a synthetic peptidomimetic drug consisting of ten amino acids, and acts as an effective and specific antagonist of bradykinin B2 receptors. It has been approved in the EU for use in hereditary angioedema, and is under investigation for a number of other conditions in which bradykinin is thought to play a significant role. https://www.creative-peptides.com/product/icatibant-item-10-101-163-33649.html






City:	Shirley[US]
Location:

Aug 09 2019	HLA-A_24_02 CMV pp65 tetramer-QYDPVAALF-PE labeled	501
Aug 09 2019	H-2Db LCMV gp33 tetramer-KAVYNFATC-APC labeled	518
Aug 09 2019	H-2Kb TRP-2 tetramer-SVYDFFVWL-PE labeled	486
Aug 09 2019	H-2Db WT1 tetramer-RMFPNAPYL-PE labeled	413
Aug 09 2019	H-2Kb HBV core tetramer-MGLKFRQL-APC labeled	496
Aug 09 2019	T-Select H-2Kb Negative (SIY) tetramer-SIYRYYGL-PE labeled	467
Aug 09 2019	T-Select H-2Kb MuLV p15E tetramer-KSPWFTTL-PE labeled	499
Aug 09 2019	T-Select H-2Kb OVA tetramer-SIINFEKL-APC labeled	531
Aug 09 2019	T-Select HLA-A_24_02 survivin-2B tetramer-AYACNTSTL-APC labeled	466
Aug 09 2019	T-Select HLA-A_02_01 CMV pp65 tetramer-NLVPMVATV-PE labeled	498